Open Text Corporation (OTEX) Stock Price Today
Aura AI Summary
Key Stats
- $5.81BMarket Cap
- -Volume
- TechnologySector
- $39.6952W High
- $20.0152W Low
- -Typical Hold Time
- $10.83BEnterprise Value
- 4.68%Div Yield
- -Trading Activity
Track Open Text Corporation (OTEX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Open Text Corporation has traded between a low of $20.01 and a high of $39.69, highlighting its annual price range. Buy and sell Open Text Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Most Recent News
Oracle stock drops 54% from peak, recovery last time took over a decade.
Oracle's stock price has fallen 54% from its highest point, marking a significant decline. Historically, when Oracle experienced a similar drop, it took more than ten years for the stock to recover fully. This long recovery period highlights potentia...

Lawsuit alleges Dick's Sporting Goods misled investors on Foot Locker acquisition impact, stock drops 30%.
Dick's Sporting Goods faces a class action lawsuit after its stock plunged 30% following disappointing financial results tied to its Foot Locker acquisition. The company missed revenue estimates and lowered its sales guidance, revealing inventory iss...

Beta Bionics sued for misleading investors on insulin pump safety, stock plunges 60% after FDA warning.
Beta Bionics faces a class action lawsuit for allegedly misleading investors about the safety and effectiveness of its iLet Bionic Pancreas insulin pump. The company claimed FDA concerns were minor and unrelated to device safety, but the FDA's warnin...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.